In this task, you are given a question and a context passage. You have to answer the question based on the given passage.

Q: Despite what improvements were there still civil issues?, Context: Between 1346 and 1354, Tai Situ Changchub Gyaltsen toppled the Sakya and founded the Phagmodrupa Dynasty. The following 80 years saw the founding of the Gelug school (also known as Yellow Hats) by the disciples of Je Tsongkhapa, and the founding of the important Ganden, Drepung and Sera monasteries near Lhasa. However, internal strife within the dynasty and the strong localism of the various fiefs and political-religious factions led to a long series of internal conflicts. The minister family Rinpungpa, based in Tsang (West Central Tibet), dominated politics after 1435. In 1565 they were overthrown by the Tsangpa Dynasty of Shigatse which expanded its power in different directions of Tibet in the following decades and favoured the Karma Kagyu sect.

A: founding of the Gelug school (also known as Yellow Hats) by the disciples of Je Tsongkhapa, and the founding of the important Ganden, Drepung and Sera monasteries near Lhasa
****
Q: What developed later, marsupials or Juramaia sinensis?, Context: The oldest known fossil among the Eutheria ("true beasts") is the small shrewlike Juramaia sinensis, or "Jurassic mother from China", dated to 160 million years ago in the Late Jurassic. A later eutherian, Eomaia, dated to 125 million years ago in the Early Cretaceous, possessed some features in common with the marsupials but not with the placentals, evidence that these features were present in the last common ancestor of the two groups but were later lost in the placental lineage. In particular:

A: marsupials
****
Q: What does the FDA oversee?, Context: In the United States, new pharmaceutical products must be approved by the Food and Drug Administration (FDA) as being both safe and effective. This process generally involves submission of an Investigational New Drug filing with sufficient pre-clinical data to support proceeding with human trials. Following IND approval, three phases of progressively larger human clinical trials may be conducted. Phase I generally studies toxicity using healthy volunteers. Phase II can include pharmacokinetics and dosing in patients, and Phase III is a very large study of efficacy in the intended patient population. Following the successful completion of phase III testing, a New Drug Application is submitted to the FDA. The FDA review the data and if the product is seen as having a positive benefit-risk assessment, approval to market the product in the US is granted.

A:
new pharmaceutical products
****